| Keywords: |
survival rate; treatment failure; clinical trial; nuclear magnetic resonance imaging; follow up; lymph node metastasis; quality of life; computer assisted tomography; editorial; diagnostic imaging; cancer invasion; symptom; contrast enhancement; decompression surgery; nephrostomy; pelvic neoplasms; outcomes research; pain assessment; urography; retroperitoneal cancer; stents; ureter obstruction; polymers; ureter stent; percutaneous nephrostomy; nephrostomy, percutaneous; ureteral obstruction; ureter stone; retroperitoneal fibrosis; coated materials, biocompatible; ureteral calculi
|
